Industry: Flexible & Barrier Packaging (Packaging)
Source: https://www.mordorintelligence.com/industry-reports/blister-packaging-market
Scraped Date: 2026-09-17
| Market Metric | Details |
|---|---|
| Base Market Size | USD 27.38 billion |
| Projected Forecast (2031) | USD 27.38 billion |
| Growth Rate (CAGR) | 4.18 % |
| Largest Market Region | N/A |
| Fastest-Growing Region | N/A |
!Major players in Blister Packaging industry
!Blister Packaging Market (2025 - 2030)
!Blister Packaging Market: Market Share by Process, 2025
!Blister Packaging Market: Market Share by Product Type, 2025
!Blister Packaging Market CAGR (%), Growth Rate by Region
!Blister Packaging Market Concentration
!Icon
!Vijeron Intelligence on Facebook
!Vijeron Intelligence on Pinterest
!Vijeron Intelligence on Instagram
!GPTW
Market OverviewStudy Period | 2020 - 2031 |
Market Size (2026) | USD 27.38 Billion |
Market Size (2031) | USD 33.59 Billion |
Growth Rate (2026 - 2031) | 4.18 % |
Fastest Growing Market | Asia Pacific |
Largest Market | Asia Pacific |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
|
Blister Packaging Market Analysis by Vijeron IntelligenceThe blister packaging market size was valued at USD 26.28 billion in 2025 and estimated to grow from USD 27.38 billion in 2026 to reach USD 33.59 billion by 2031, at a CAGR of 4.18% during the forecast period (2026-2031). Robust demand from prescription drugs, over-the-counter medications, and increasingly complex biologics underpins this growth, while unit-dose formats continue to displace bulk bottles across hospital, long-term-care, and retail channels. Regulatory pressure—most notably the European Union’s Regulation 2025/40 mandating full recyclability by 2030 and the U.S. FDA’s strengthened tamper-evident rules—has sparked a wave of compliance-driven innovation that commands premium pricing and protects margins even as raw-material costs fluctuate.[1]European Commission, “Regulation (EU) 2025/40 on Packaging and Packaging Waste,” eur-lex.europa.eu Asia-Pacific leads global demand thanks to China and India’s manufacturing scale, while North America and Europe shape high-value niches through serialization, smart packs, and sustainability upgrades. Meanwhile, industry consolidation—typified by Amcor’s USD 8.43 billion purchase of Berry Global—signals a pivot toward integrated flexible, rigid, and intelligent solutions that can serve multinational pharmaceutical clients.
Key Report Takeaways* By process, thermoforming led with 63.75% of the blister packaging market share in 2025 and is progressing at a 5.54% CAGR through 2031.
Market Trends and InsightsDrivers Impact Analysis of Blister Packaging Market*Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
Growing geriatric population & chronic diseases | +1.2% | Global; North America & Europe concentrated | Long term (≥ 4 years) |
Rising demand for unit-dose adherence packs | +0.8% | Global; strongest in developed markets | Medium term (2-4 years) |
Regulatory push for tamper-evident formats | +0.6% | North America & EU; APAC catching up | Short term (≤ 2 years) |
Smart packs with NFC/QR for track-and-trace | +0.4% | EU & North America first; global roll-out | Medium term (2-4 years) |
Personalized-medicine small-batch blister lines | +0.3% | North America & EU core | Long term (≥ 4 years) |
PVC-to-PE retrofits driven by sustainability targets | +0.2% | EU leading; global adoption follows | Medium term (2-4 years) |
Source: Vijeron Intelligence |
Competitive Landscape
The blister packaging market sits in the mid-range of concentration. Top players—Amcor, Constantia Flexibles, WestRock, and select regional specialists—collectively control an estimated two-thirds of global pharmaceutical blister capacity. Consolidation is accelerating: Amcor’s USD 8.43 billion purchase of Berry Global cements a healthcare-focused powerhouse that targets USD 650 million in cost synergies within three years. Meanwhile, Nutra-Med’s acquisition of Legacy Pharma Solutions equips the nutraceutical co-packer with high-speed blistering to address dietary-supplement growth.
Technology differentiation drives competitive edge. Pharmaworks’ TF1e blister machine caters to mid-volume drug makers seeking GMP compliance without the footprint of legacy lines. Ecobliss Pharma’s cold-seal technology lowers energy consumption, aligning with decarbonization targets while preserving high-barrier protection. Patent filings on single-piece re-closable unit packs reveal sustained R&D investment into user-friendly, adherence-boosting formats. As sustainability and digital traceability become table stakes, innovators capable of integrating post-consumer recycled content with embedded electronics are positioned to outpace conventional rivals.
Smaller converters focus on niche strengths—specialty films, rapid-changeover lines, or country-specific compliance expertise—to capture high-margin contracts that global majors overlook. Strategic partnerships between machinery OEMs and material suppliers further erode barriers for mid-tier entrants, keeping the blister packaging industry dynamic despite headline consolidation.
Blister Packaging Industry Leaders* Klockner Pentaplast Group
Image © Vijeron Intelligence. Reuse requires attribution under CC BY 4.0.
For this study, the blister packaging market covers the revenue generated from blister packs used to protect, display, and unit-dose products. Revenue is counted at the packaging supply level and reported in USD for the covered geographies.
Scope exclusions: We exclude secondary packaging formats that are not blister packs, as well as unrelated packaging machinery and services.
The blister packaging market size is USD 27.38 billion in 2026 and is projected to reach USD 33.59 billion by 2031 at a 4.18% CAGR.
Asia-Pacific leads growth with a 7.29% CAGR through 2031, driven by pharmaceutical production expansion in China and India.
Thermoforming holds 63.75% of global revenue and remains preferred for its cost-efficiency and high throughput.
EU Regulation 2025/40 mandates recyclability and recycled-content thresholds, accelerating the shift from PVC toward recyclable PET and paper-based structures.
NFC and QR-enabled blisters meet serialization laws and allow real-time adherence monitoring, improving patient outcomes and supply-chain visibility.
Volatile PVC and aluminium costs can shave up to 0.9 percentage points off forecast CAGR, pressuring margins and hastening industry consolidation.